Arginine

Arginine (abbreviated Arg or R; systematically named (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid, molecular formula C6H14N4O2, molecular mass 174.20 Da) is a conditionally essential, cationic α-amino acid incorporated into proteins during translation. First isolated in 1886 by German chemists Ernst Schulze and Ernst Steiger from yellow lupin (Lupinus luteus) seedling extracts and named from the Greek argyros ("silver") due to the silvery appearance of its nitrate salt crystals, L-arginine possesses a three-carbon aliphatic propyl chain (-CH2-CH2-CH2-) terminating in a resonance-stabilized guanidinium group (-NH-C(=NH2+)-NH2). With a side-chain acid dissociation constant of pKa3 ≈ 12.48 to 13.8 and an isoelectric point of pI = 10.76, arginine is the most basic of all twenty canonical amino acids, remaining protonated (+1 net charge) across both aqueous physiological environments and hydrophobic membrane interiors. Specified by six codons (CGU, CGC, CGA, CGG, AGA, and AGG) in the standard genetic code, arginine coordinates phosphate backbones in histones and ATP-binding enzymes, serves as the precursor of urea in the hepatic Krebs-Henseleit urea cycle, provides the guanidino nitrogen oxidized by nitric oxide synthases (NOS) to generate the signaling gas nitric oxide (•NO), and supplies the amidino group for creatine biosynthesis.

Along with lysine (pKa3 ≈ 10.54) and histidine (pKa3 ≈ 6.00), L-arginine belongs to the class of positively charged (basic) proteinogenic amino acids. Its carboxylic acid group exhibits pKa1 = 2.17 and its α-amino group exhibits pKa2 = 9.04.

Y-Delocalized Resonance and Bidentate Hydrogen Bonding

The strong basicity of the arginine side chain (pKa3 ≈ 12.48 by potentiometry, revised to 13.8 ± 0.1 by 13C/15N NMR) derives from its terminal guanidinium cation (-NH-C(NH2)2+). Protonation delocalizes the +1 formal charge symmetrically across all three sp2-hybridized nitrogens (Nε, Nη1, Nη2) and the central Cζ carbon via Y-conjugation (6 π-electrons over 4 atoms, equal Cζ–N bond lengths of ~1.33 Å). This planar geometry confers three biophysical properties:

1. Five-Donor Bidentate Salt Bridges: Five coplanar N–H donors form cyclic bidentate salt bridges with carboxylate side chains (Asp−, Glu−) and tetrahedral phosphodiester/pyrophosphate oxygens in DNA, RNA, and ATP/GTP.
2. Cation–π Stacking: The flat guanidinium π-system stacks parallel against the electron-rich aromatic rings of Trp, Tyr, and Phe (~10–25 kJ/mol).
3. Persistent Protonation in Lipid Bilayers: Unlike lysine (pKa ≈ 10.5), arginine (pKa = 13.8) remains protonated (+1) inside hydrophobic membrane cores, enabling conserved arginines on the S4 transmembrane α-helix of voltage-gated Na+, K+, and Ca2+ channels to act as the voltage-sensing paddle and enabling cell-penetrating peptides (CPPs) (HIV-1 Tat) to cross membranes.

DNA Recognition, Nucleosome Wrapping, and Enzyme Catalysis

Within the eukaryotic nucleosome, core histones (H3 and H4 contain 10–14% arginine) insert "sprocket" arginine side chains (H3-Arg49, H3-Arg83, H4-Arg45) into the 14 inward-facing minor-groove sites of the 147-bp DNA duplex to bend DNA around the octamer, while sperm protamines (50–70% arginine) condense paternal chromatin into toroids. In P-loop NTPases (Ras, Gα, AAA+ ATPases, and α-Arg373 of F₁-ATP synthase), catalytic "arginine fingers" neutralize negative charge on the pentavalent γ-phosphate transition state during ATP/GTP hydrolysis, while R-SNAREs (VAMP2) contribute a conserved arginine to the 3Q:1R zero-layer of SNARE complexes.

In ureotelic vertebrates (mammals and adult amphibians), L-arginine is the immediate metabolic precursor of urea ((NH2)2C=O) in the urea cycle (discovered by Hans Krebs and Kurt Henseleit in 1932).

Enzymatic Steps of the Krebs-Henseleit Urea Cycle

Operating across the mitochondrial matrix and cytosol of periportal hepatocytes, the urea cycle detoxifies neurotoxic ammonia (NH4+) generated by amino acid catabolism:

1. Carbamoyl Phosphate Synthesis (Mitochondrial Matrix): Carbamoyl phosphate synthetase I (CPS1, allosterically activated by N-acetylglutamate) condenses NH4+ and HCO3− at the expense of 2 ATP to form carbamoyl phosphate.
2. Citrulline Formation (Mitochondrial Matrix): Ornithine transcarbamoylase (OTC) transfers the carbamoyl group to L-ornithine, producing L-citrulline, which exits the mitochondrion into the cytosol via the ORNT1 (SLC25A15) ornithine/citrulline antiporter.
3. Argininosuccinate Synthesis (Cytosol): Argininosuccinate synthetase (ASS1) condenses the ureido group of L-citrulline with the α-amino group of L-aspartate (driven by ATP → AMP + PPi hydrolysis) to form argininosuccinate.
4. Arginine Generation (Cytosol): Argininosuccinate lyase (ASL) cleaves argininosuccinate via a β-elimination into L-arginine and fumarate (which returns to the citric acid cycle as malate to regenerate aspartate).
5. Hydrolytic Cleavage by Arginase I (ARG1): Cytosolic Arginase I (ARG1), a binuclear manganese (Mn2+2) metalloenzyme expressed in the liver, hydrolyzes the guanidinium group of L-arginine to release urea (excreted by the kidneys) and regenerate L-ornithine, completing the cycle.

Why Arginine Is Conditionally Essential: The Intestinal-Renal Axis

Because hepatic ARG1 activity is very high, nearly 100% of the arginine synthesized within the hepatic urea cycle is hydrolyzed into urea and ornithine inside the hepatocyte; the liver exports negligible net free arginine into the systemic circulation. Instead, endogenous systemic L-arginine synthesis (~15–20% of daily plasma arginine flux, ~4–6 g/day in adult humans) relies on an intestinal-renal interorgan axis: small intestinal enterocytes convert dietary glutamine, glutamate, and proline into L-citrulline, which bypasses the liver and is extracted by renal proximal convoluted tubule cells (which express ASS1 and ASL but lack ARG1) to synthesize L-arginine and secrete it into the bloodstream.

Consequently, while healthy adults synthesize sufficient arginine via this gut-kidney axis, L-arginine becomes a conditionally essential amino acid in premature infants (who lack mature intestinal CPS1/OTC expression) and in patients with sepsis, major burns, or trauma, where myeloid Arginase I and inducible nitric oxide synthase (iNOS) deplete plasma arginine. Carnivores such as cats (felids) lack intestinal pyrroline-5-carboxylate synthase activity altogether, making dietary arginine required at every meal to prevent hyperammonemia.

1. The Nitric Oxide Synthase (NOS) Pathway, Creatine, and Polyamines

Discovered by Robert F. Furchgott, Louis J. Ignarro, Ferid Murad (1998 Nobel Prize in Physiology or Medicine) and Salvador Moncada as Endothelium-Derived Relaxing Factor (EDRF), the free-radical signaling gas nitric oxide (•NO) is synthesized from the terminal guanidino nitrogen of L-arginine by homodimeric Nitric Oxide Synthase (NOS, EC 1.14.13.39) isozymes (eNOS/NOS3 in vascular endothelium, nNOS/NOS1 in neurons, and inducible iNOS/NOS2 in macrophages) requiring heme, tetrahydrobiopterin (BH4), FAD, FMN, and calmodulin (Ca2+/CaM):

L-Arginine + 2 O2 + 1.5 NADPH + 1.5 H+ → L-Citrulline + •NO + 2 H2O + 1.5 NADP+

Endothelial •NO diffuses into adjacent vascular smooth muscle cells and binds the ferrous heme of soluble guanylate cyclase (sGC), stimulating GTP → cGMP conversion and activating protein kinase G (PKG) to cause vasodilation and lower blood pressure. In parallel, ~20–30% of endogenous arginine amidino groups are transferred by renal L-arginine:glycine amidinotransferase (AGAT) onto glycine to form guanidinoacetate, which hepatic GAMT methylates using S-adenosylmethionine (SAM) to synthesize creatine → phosphocreatine. Additionally, ornithine derived from arginase is decarboxylated by ornithine decarboxylase (ODC1) into putrescine → spermidine → spermine for cell proliferation.

2. Epigenetic Modifications: Histone Methylation (PRMTs) and Citrullination (PADs)

In chromatin biology and epigenetics, post-translational modification of arginine guanidinium side chains on histones (H3R2, H3R8, H3R17, H4R3) regulates gene expression and innate immunity:

• Arginine Methylation by PRMT1–9: Nine mammalian Protein Arginine Methyltransferases transfer methyl groups from SAM to the terminal ω-guanidino nitrogens. Type I PRMTs (PRMT1, CARM1/PRMT4) generate asymmetric dimethylarginine (ADMA) (such as co-activating H4R3me2a and H3R17me2a; when proteolyzed, free circulating ADMA acts as an endogenous competitive inhibitor of eNOS in cardiovascular disease), whereas Type II PRMTs (PRMT5, PRMT9) generate symmetric dimethylarginine (SDMA) (such as repressive H4R3me2s).
• Citrullination (Deimination) by PAD1–4: Calcium-dependent Peptidylarginine Deiminases hydrolyze the positively charged guanidinium group of protein-bound arginine into a neutral ureido group (peptidyl-citrulline, loss of +1 charge). In neutrophils, nuclear PAD4 citrullinates histones H3 and H4 to drive chromatin decondensation and extrusion of Neutrophil Extracellular Traps (NETs / NETosis), whereas extracellular citrullination in inflamed joints generates the neoantigens targeted by anti-citrullinated protein antibodies (ACPAs / anti-CCP) in rheumatoid arthritis.

Why is arginine more basic than lysine?

In lysine (pKa3 ≈ 10.54), protonation of the terminal ε-amino group places the positive charge onto a single sp3-hybridized ammonium nitrogen (-CH2-NH3+) with no π-resonance stabilization. By contrast, protonation of arginine's side chain yields the planar guanidinium cation (-NH-C(NH2)2+), in which the +1 charge is delocalized equally across all three sp2-hybridized nitrogen atoms and the central Cζ carbon via Y-aromatic conjugation (6 π-electrons over 4 atoms). Because deprotonating guanidinium disrupts this symmetric three-center resonance stabilization, arginine resists losing a proton until pH 12.5–13.8, remaining positively charged in all biological environments.

If the liver synthesizes large amounts of arginine in the urea cycle, why does the body still need the kidneys to make plasma arginine?

Although periportal hepatocytes synthesize L-arginine from citrulline and aspartate at step 4 of the urea cycle, hepatocytes simultaneously express high concentrations of cytosolic Arginase I (ARG1) channeled to argininosuccinate lyase (ASL). As a result, nearly 100% of hepatic urea-cycle arginine is cleaved into urea and ornithine inside the liver and never enters the general circulation. Systemic plasma arginine synthesis instead relies on the intestinal-renal axis: small intestinal enterocytes synthesize L-citrulline from glutamine and proline, which bypasses the liver and is taken up by renal proximal tubule cells (which express ASS1 and ASL but lack ARG1) to produce circulating L-arginine.

What is the "arginine paradox" in nitric oxide cardiovascular physiology?

The intracellular Michaelis constant (Km) of purified endothelial nitric oxide synthase (eNOS) for L-arginine is approximately 2–5 μM, whereas intracellular L-arginine concentrations in vascular endothelial cells are 100–800 μM (20- to 200-fold above Km, where eNOS should be >98% saturated). Yet administering exogenous L-arginine or L-citrulline clinically increases •NO production and improves endothelium-dependent vasodilation. This "arginine paradox" is explained by two mechanisms: first, endogenous competitive inhibitors such as asymmetric dimethylarginine (ADMA) accumulate in cardiovascular disease and raise the apparent Km of eNOS, and second, eNOS residing in caveolae is preferentially channeled extracellular L-arginine imported via the CAT-1 (SLC7A1) cationic amino acid transporter.

1. Morris, S. M., Jr. (2016). "Arginine metabolism revisited." The Journal of Nutrition, 146(12), 2579S–2586S. https://doi.org/10.3945/jn.115.226621
2. Fitch, C. A., Platzer, G., Okon, M., Garcia-Moreno E., B., & McIntosh, L. P. (2015). "Arginine: Its pK_a value revisited." Protein Science, 24(5), 752–761. https://doi.org/10.1002/pro.2647
3. Förstermann, U., & Sessa, W. C. (2012). "Nitric oxide synthases: Regulation and function." European Heart Journal, 33(7), 829–837. https://doi.org/10.1093/eurheartj/ehr304
4. Blanc, R. S., & Richard, S. (2017). "Arginine methylation: The coming of age." Molecular Cell, 65(1), 8–24. https://doi.org/10.1016/j.molcel.2016.11.003